w*********7
发帖数: 2883 | 1 来自主题: _pennystock版 - INCY 好消息？
Incyte Corporation (Nasdaq:INCY) today announced that further analyses from
the global, pivotal Phase III clinical program of Jakafi (ruxolitinib or
INC424) are being presented at the 2011 American Society of Hematology (ASH)
Annual Meeting. |
|
